The Role of Toll-Like Receptor 2 and 4 Innate Immunity Pathways in Intracortical Microelectrode-Induced Neuroinflammation.

Published

Journal Article

We have recently demonstrated that partial inhibition of the cluster of differentiation 14 (CD14) innate immunity co-receptor pathway improves the long-term performance of intracortical microelectrodes better than complete inhibition. We hypothesized that partial activation of the CD14 pathway was critical to a neuroprotective response to the injury associated with initial and sustained device implantation. Therefore, here we investigated the role of two innate immunity receptors that closely interact with CD14 in inflammatory activation. We implanted silicon planar non-recording neural probes into knockout mice lacking Toll-like receptor 2 (Tlr2-/-), knockout mice lacking Toll-like receptor 4 (Tlr4-/-), and wildtype (WT) control mice, and evaluated endpoint histology at 2 and 16 weeks after implantation. Tlr4-/- mice exhibited significantly lower BBB permeability at acute and chronic time points, but also demonstrated significantly lower neuronal survival at the chronic time point. Inhibition of the Toll-like receptor 2 (TLR2) pathway had no significant effect compared to control animals. Additionally, when investigating the maturation of the neuroinflammatory response from 2 to 16 weeks, transgenic knockout mice exhibited similar histological trends to WT controls, except that knockout mice did not exhibit changes in microglia and macrophage activation over time. Together, our results indicate that complete genetic removal of Toll-like receptor 4 (TLR4) was detrimental to the integration of intracortical neural probes, while inhibition of TLR2 had no impact within the tests performed in this study. Therefore, approaches focusing on incomplete or acute inhibition of TLR4 may still improve intracortical microelectrode integration and long term recording performance.

Full Text

Duke Authors

Cited Authors

  • Hermann, JK; Lin, S; Soffer, A; Wong, C; Srivastava, V; Chang, J; Sunil, S; Sudhakar, S; Tomaszewski, WH; Protasiewicz, G; Selkirk, SM; Miller, RH; Capadona, JR

Published Date

  • January 2018

Published In

Volume / Issue

  • 6 /

Start / End Page

  • 113 -

PubMed ID

  • 30159311

Pubmed Central ID

  • 30159311

Electronic International Standard Serial Number (EISSN)

  • 2296-4185

International Standard Serial Number (ISSN)

  • 2296-4185

Digital Object Identifier (DOI)

  • 10.3389/fbioe.2018.00113

Language

  • eng